Patent Document ID: 7943328
Application ID: 11679149

Base Claim:
1. A method for classifying whether a sample from an individual not having inflammatory bowel disease (IBD) is associated with irritable bowel syndrome (IBS), the method comprising: (a) measuring a concentration level of at least one marker in said sample, wherein said at least one marker comprises an anti-flagellin antibody; and (b) applying a combination of at least two learning statistical classifier systems to the measured concentration level of said at least one marker to classify said sample as an IBS sample or as a non-IBS sample.

---

Claim 2:
2. The method of claim 1 , wherein said at least one marker further comprises an anti-neutrophil cytoplasmic antibody (ANCA), an anti- Saccharomyces cerevisiae immunoglobulin A antibody (ASCA-IgA), an anti- Saccharomyces cerevisiae immunoglobulin G antibody (ASCA-IgG), an anti-outer membrane protein C (anti-OmpC) antibody, an anti-I2 antibody, a perinuclear anti-neutrophil cytoplasmic antibody (pANCA), or combinations thereof.